Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 5. Effect of efonidipine on the cell migration in LPS-stimulated BV2 and HMC3 cells. (A, B) BV2 cells were co-treated with LPS (1 µg/mL) and the indicated concentrations of efonidipine for 24 h. After treatment, the degrees of cell migration were determined by transwell migration (A) and wound healing assays (B), as described in the Materials and methods. (C, D) HMC3 cells were co-treated with LPS (0.1 µg/mL) and the indicated concentrations of efonidipine for 24 h. The effect of efonidipine on the migration of HMC3 cells was assessed by transwell migration (C) and wound healing assays (D). The data are presented as the mean ± SEM of at least three independent experiments (#p<0.05 vs. vehicle-treated control cells; *p<0.05 vs. LPS-treated cells). LPS: lipopolysaccharide, Efo: Efonidipine.
Biomolecules & Therapeutics 2022;30:455~464 https://doi.org/10.4062/biomolther.2022.076
© Biomolecules & Therapeutics